je.st
news
Tag: iii
Furniture Icon John Bassett, III to Speak at AWFS Fair
2015-03-10 05:40:52| Furniture - Topix.net
The Association of Woodworking & Furnishings Suppliers is pleased to announce that John Bassett, III will be a Special Guest Speaker at the 2015 AWFSFair in Las Vegas, sharing his personal story of standing up to China's dumping of cheap furniture into the American market, as portrayed in the New York Times bestseller, Factory Man , written by Beth Macy. A dynamic storyteller and passionate individual, Mr. Bassett will share how his company faced extreme challenges when China began dumping cheap furniture into the American market in the 1980s.
GE Delivers Its First IMO Tier III Compliant Marine Diesel Engines to Northern European Market
2015-02-17 11:30:57| Industrial Newsroom - All News for Today
Bast Fosen orders eight engines from GE Marine CHICAGO GE Marine announced that Bast Fosen has chosen GE Marines International Maritime Organization (IMO) Tier III compliant marine diesel engines for new and repowered vessels. Bast Fosen will be among the first customers in Northern Europe to operate GEs...
Tags: market
iii
european
northern
AEMC's PowerPad III Wins Product of the Year!
2015-02-13 11:30:28| Industrial Newsroom - All News for Today
Three-Phase Power Quality Analyzer Measures AC and DC CHESTERLAND OH CAS DataLoggers is proud to announce that the popular AEMC PowerPad III Power Quality Analyzer Model 8333 has just been named a 2014 Product of the Year Winner by Utility Products Magazine! The PowerPad III is featured on the cover of the...
Sustainability in Beer - Part III: Water Stewardship, Supply Chains and Building Prosperity
2015-02-12 10:21:00| Daily beverage news and comment - from just-drinks.com
The penultimate part of this month's sustainability management briefing, which focuses on the global brewing category, considers some of the more specific details of brewers' programmes in the coming years.
GSK and Theravance Announce Start of Phase III Lung Function Study...
2015-02-10 06:04:15| Biotech - Topix.net
Enrolling approximately 1,800 patients, the FULFIL study will assess whether the inhaled corticosteroid, long-acting muscarinic antagonist and long-acting beta2-adrenergic agonist combination, all delivered in GSK's ElliptaA inhaler, can improve lung function and health-related quality of life compared with budesonide/formoterol, a twice-daily ICS/LABA combination delivered via the TurbohalerA dry powder inhaler. Secondary objectives include investigating the effect on the rate of exacerbations with FF/UMEC/VI compared with budesonide/formoterol, and the safety profile of FF/UMEC/VI compared with budesonide/formoterol.
Tags: start
study
iii
function
Sites : [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] next »